Recently it was shown that propranolol can be used to suppress the formation of hemangiomas in the lungs of COVID-19 patients by suppressing the expression of ANGPTL4 [165], providing a potential mechanism of action for propranolol in treating hemangiomas. This evidence concerns the gene ANGPTL4 and hemangioma.